Ubs Group Ag Repare Therapeutics Inc. Transaction History

Ubs Group Ag

$527 Billion
Q4 2024

A detailed history of Ubs Group Ag transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Ubs Group Ag holds 15,303 shares of RPTX stock, worth $19,281. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,303

Holding current value

$19,281

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$1.25 - $3.97 $19,128 - $60,752	15,303 New	15,303 $20,000
Q1 2024 May 13, 2024	BUY	$4.53 - $8.41 $2,314 - $4,297	511 Added 7300.0%	518 $2,000
Q4 2023 Feb 09, 2024	SELL	$3.22 - $11.79 $5,950 - $21,787	-1,848 Reduced 99.62%	7 $0
Q3 2023 Nov 09, 2023	SELL	$8.16 - $13.01 $22,758 - $36,284	-2,789 Reduced 60.06%	1,855 $22,000
Q2 2023 Aug 11, 2023	BUY	$8.63 - $12.53 $21,281 - $30,898	2,466 Added 113.22%	4,644 $49,000
Q1 2023 May 12, 2023	SELL	$9.32 - $15.06 $26,692 - $43,131	-2,864 Reduced 56.8%	2,178 $21,000
Q4 2022 Feb 08, 2023	BUY	$12.5 - $18.13 $18,637 - $27,031	1,491 Added 41.99%	5,042 $74,000
Q3 2022 Nov 10, 2022	BUY	$11.57 - $15.59 $8,550 - $11,521	739 Added 26.28%	3,551 $43,000
Q2 2022 Aug 10, 2022	SELL	$8.45 - $14.84 $4,495 - $7,894	-532 Reduced 15.91%	2,812 $39,000
Q1 2022 May 16, 2022	SELL	$11.38 - $21.88 $27,312 - $52,512	-2,400 Reduced 41.78%	3,344 $48,000
Q4 2021 Feb 14, 2022	BUY	$19.66 - $28.11 $41,128 - $58,806	2,092 Added 57.28%	5,744 $121,000
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $53,836 - $73,792	-2,094 Reduced 36.44%	3,652 $96,000
Q2 2021 Aug 13, 2021	BUY	$30.1 - $34.85 $130,393 - $150,970	4,332 Added 306.36%	5,746 $179,000
Q1 2021 May 12, 2021	BUY	$25.89 - $44.46 $31,430 - $53,974	1,214 Added 607.0%	1,414 $43,000
Q4 2020 Feb 11, 2021	SELL	$23.42 - $39.5 $10,866 - $18,328	-464 Reduced 69.88%	200 $7,000
Q3 2020 Nov 12, 2020	BUY	$21.55 - $33.92 $14,309 - $22,522	664 New	664 $20,000

Others Institutions Holding RPTX

# of Institutions

Shares Held

33.6M

Call Options Held

51K

Put Options Held

Bvf Inc San Francisco, CA

10.3M
Shares

$13 Million
0.51% of portfolio
Blue Owl Capital Holdings LP New York, NY

3.44M
Shares

$4.34 Million
1.93% of portfolio
Orbimed Advisors LLC San Diego, CA

3.32M
Shares

$4.19 Million
0.12% of portfolio
Chi Advisors LLC New York, NY

2.97M
Shares

$3.74 Million
17.66% of portfolio
Versant Venture Management, LLC San Francisco, CA

2.65M
Shares

$3.33 Million
5.13% of portfolio

View Full List

About Repare Therapeutics Inc.

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $52.8M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

More about RPTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account